+30.4%
GSK vs SPG
+21.3%
+9.1%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.0% | -0.9% | -1.4% |
| 7D | -1.8% | -2.4% | +0.6% | -0.5% |
| 30D | -2.2% | -6.8% | +4.7% | +1.7% |
| 3M | -1.8% | +2.7% | -4.5% | -2.9% |
| 6M | -10.6% | +5.5% | -16.1% | -12.9% |
| YTD | +4.4% | +15.7% | -11.3% | -1.6% |
| 1Y | +30.4% | +20.9% | +9.5% | +22.3% |
| All | +30.4% | +21.3% | +9.1% | +22.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SPG.
Daily Out/Under-Performance
Portfolio return minus SPG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling